Antilipoprotein lipase (anti-LPL) antibodies have been recently described in rheumatic diseases, mainly in systemic lupus erythematosus (SLE) and systemic sclerosis (SSc) but also in polymyositis and rheumatoid arthritis [1]. The gene discussed is LPL; the disease is systemic sclerosis.